Log in

NYSE:WAT - Waters Stock Price, Forecast & News

$216.38
-0.96 (-0.44 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$215.08
Now: $216.38
$217.08
50-Day Range
$216.06
MA: $227.88
$244.09
52-Week Range
$199.11
Now: $216.38
$255.21
Volume436,230 shs
Average Volume513,349 shs
Market Capitalization$13.94 billion
P/E Ratio24.64
Dividend YieldN/A
Beta1.1
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.41 billion
Cash Flow$11.09 per share
Book Value($3.36) per share

Profitability

Net Income$592.20 million

Miscellaneous

Employees7,200
Market Cap$13.94 billion
Next Earnings Date4/28/2020 (Estimated)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.


Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters announced that its board has approved a stock repurchase program on Tuesday, April 24th 2018, which allows the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 18.2% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board of directors believes its stock is undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) announced its quarterly earnings results on Tuesday, February, 4th. The medical instruments supplier reported $3.20 EPS for the quarter, topping analysts' consensus estimates of $3.01 by $0.19. The medical instruments supplier earned $716 million during the quarter, compared to the consensus estimate of $714.34 million. Waters had a net margin of 24.61% and a return on equity of 172.16%. The firm's quarterly revenue was up .1% on a year-over-year basis. During the same period in the previous year, the business posted $2.87 earnings per share. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, April 28th 2020. View Earnings Estimates for Waters.

What guidance has Waters issued on next quarter's earnings?

Waters issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share (EPS) guidance of $9.15-$9.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.80.

What price target have analysts set for WAT?

11 brokerages have issued 12-month price targets for Waters' shares. Their forecasts range from $177.00 to $230.00. On average, they expect Waters' share price to reach $203.71 in the next year. This suggests that the stock has a possible downside of 5.9%. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

Has Waters been receiving favorable news coverage?

News headlines about WAT stock have trended somewhat negative on Sunday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a media sentiment score of -1.8 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Waters.

Are investors shorting Waters?

Waters saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 6,090,000 shares, an increase of 5.4% from the January 15th total of 5,780,000 shares. Based on an average trading volume of 458,300 shares, the days-to-cover ratio is presently 13.3 days. Currently, 9.5% of the company's stock are short sold. View Waters' Current Options Chain.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), CVS Health (CVS), Procter & Gamble (PG), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

Who are Waters' major shareholders?

Waters' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (8.71%), Bank of New York Mellon Corp (7.14%), State Street Corp (4.50%), Baillie Gifford & Co. (3.68%), Janus Henderson Group PLC (2.55%) and Champlain Investment Partners LLC (1.55%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

Which major investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., FMR LLC, State Street Corp, Baillie Gifford & Co., Jensen Investment Management Inc., Pictet Asset Management Ltd., Triodos Investment Management BV and Trillium Asset Management LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael J Berendt, Robert G Carson and Terrence P Kelly. View Insider Buying and Selling for Waters.

Which major investors are buying Waters stock?

WAT stock was bought by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC, Amundi Pioneer Asset Management Inc., Man Group plc, Great West Life Assurance Co. Can, Credit Suisse AG, Mawer Investment Management Ltd., Bank of New York Mellon Corp and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $216.38.

How big of a company is Waters?

Waters has a market capitalization of $13.94 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

What is Waters' official website?

The official website for Waters is http://www.waters.com/.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  408 (Vote Outperform)
Underperform Votes:  561 (Vote Underperform)
Total Votes:  969
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel